Krka d. d
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company's prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolis… Read more
Market Cap & Net Worth: Krka d. d (KRK)
Krka d. d (WAR:KRK) has a market capitalization of $7.26 Billion (zł30.17 Billion) as of March 18, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #3082 globally and #7 in its home market, demonstrating a 1.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Krka d. d's stock price zł988.00 by its total outstanding shares 30540879 (30.54 Million).
Krka d. d Market Cap History: 2015 to 2026
Krka d. d's market capitalization history from 2015 to 2026. Data shows growth from $1.31 Billion to $7.26 Billion (18.49% CAGR).
Krka d. d Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Krka d. d's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.25x
Krka d. d's market cap is 2.25 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
12.06x
Krka d. d's market cap is 12.06 times its annual earnings
10.35x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.31 Billion | $1.16 Billion | $158.25 Million | 1.12x | 8.27x |
| 2016 | $1.20 Billion | $1.17 Billion | $108.45 Million | 1.03x | 11.11x |
| 2017 | $1.19 Billion | $1.27 Billion | $152.60 Million | 0.94x | 7.82x |
| 2018 | $1.32 Billion | $1.33 Billion | $174.59 Million | 0.99x | 7.58x |
| 2019 | $1.74 Billion | $1.49 Billion | $245.54 Million | 1.17x | 7.10x |
| 2020 | $2.55 Billion | $1.53 Billion | $291.00 Million | 1.66x | 8.76x |
| 2021 | $3.42 Billion | $1.57 Billion | $309.21 Million | 2.19x | 11.07x |
| 2022 | $2.87 Billion | $1.72 Billion | $363.30 Million | 1.67x | 7.90x |
| 2023 | $3.37 Billion | $1.81 Billion | $313.95 Million | 1.87x | 10.74x |
| 2024 | $4.30 Billion | $1.91 Billion | $356.99 Million | 2.25x | 12.06x |
Competitor Companies of KRK by Market Capitalization
Companies near Krka d. d in the global market cap rankings as of March 18, 2026.
Key companies related to Krka d. d by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Krka d. d Historical Marketcap From 2015 to 2026
Between 2015 and today, Krka d. d's market cap moved from $1.31 Billion to $ 7.26 Billion, with a yearly change of 18.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł7.26 Billion | +14.88% |
| 2025 | zł6.32 Billion | +46.76% |
| 2024 | zł4.30 Billion | +27.63% |
| 2023 | zł3.37 Billion | +17.54% |
| 2022 | zł2.87 Billion | -16.20% |
| 2021 | zł3.42 Billion | +34.28% |
| 2020 | zł2.55 Billion | +46.35% |
| 2019 | zł1.74 Billion | +31.68% |
| 2018 | zł1.32 Billion | +10.85% |
| 2017 | zł1.19 Billion | -0.94% |
| 2016 | zł1.20 Billion | -7.96% |
| 2015 | zł1.31 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Krka d. d was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.26 Billion USD |
| MoneyControl | $7.26 Billion USD |
| MarketWatch | $7.26 Billion USD |
| marketcap.company | $7.26 Billion USD |
| Reuters | $7.26 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.